Insider Transactions in Q3 2021 at Acumen Pharmaceuticals, Inc. (ABOS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 06
2021
|
Sands Capital Ventures Discovery Fund Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
450,000
+11.64%
|
$6,300,000
$14.88 P/Share
|
|
Jul 06
2021
|
Sands Capital Ventures Discovery Fund Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,967,075
+44.15%
|
-
|
|
Jul 06
2021
|
Nathan B Fountain Director |
BUY
Open market or private purchase
|
Direct |
6,250
+50.0%
|
$100,000
$16.0 P/Share
|
|
Jul 06
2021
|
Robert D. Hardie > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,062,500
+12.24%
|
$17,000,000
$16.0 P/Share
|
|
Jul 06
2021
|
Robert D. Hardie > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,809,625
+47.15%
|
-
|
|
Jul 06
2021
|
Daniel Joseph O Connell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-0.63%
|
$160
$16.0 P/Share
|
|
Jul 06
2021
|
Daniel Joseph O Connell President and CEO |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
35
+2.17%
|
$140
$4.47 P/Share
|
|
Jul 06
2021
|
Daniel Joseph O Connell President and CEO |
BUY
Conversion of derivative security
|
Direct |
123
+7.39%
|
-
|
|
Jul 06
2021
|
John A Stalfort Iii Director |
BUY
Conversion of derivative security
|
Indirect |
131,595
+50.0%
|
-
|
|
Jul 06
2021
|
John A Stalfort Iii Director |
BUY
Open market or private purchase
|
Direct |
35,000
+16.88%
|
$560,000
$16.0 P/Share
|
|
Jul 06
2021
|
John A Stalfort Iii Director |
BUY
Conversion of derivative security
|
Direct |
130,180
+48.66%
|
-
|
|
Jul 06
2021
|
Matt Zuga CFO & Chief Business Officer |
BUY
Conversion of derivative security
|
Direct |
26,187
+50.0%
|
-
|
|
Jul 06
2021
|
Paul B Manning > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,608,469
+49.63%
|
-
|
|
Jul 06
2021
|
Paul B Manning > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
312,500
+8.53%
|
$5,000,000
$16.0 P/Share
|
|
Jul 06
2021
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
7,895,773
+50.0%
|
-
|
|
Jul 06
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,875,000
+13.21%
|
$30,000,000
$16.0 P/Share
|